Search results
Industry groups back drugmakers' appeal in Zantac cancer lawsuits
Reuters via AOL· 3 days agoA bid by GSK and other drugmakers to stop more than 70,000 lawsuits in Delaware over discontinued...
PNC Financial Services Group Inc. Has $11.03 Million Position in GSK plc (NYSE:GSK)
ETF DAILY NEWS· 5 days agoPNC Financial Services Group Inc. reduced its position in shares of GSK plc (NYSE:GSK – Free Report) by 27.5% during the 4th quarter, according to the company ...
Trust Co. of Toledo NA OH Acquires 6,696 Shares of GSK plc (NYSE:GSK)
ETF DAILY NEWS· 4 days agoTrust Co. of Toledo NA OH boosted its position in shares of GSK plc (NYSE:GSK – Free Report) by 37.3% in the 1st quarter, according to its most recent filing ...
NBC Securities Inc. Has $1.43 Million Stock Holdings in GSK plc (NYSE:GSK)
ETF DAILY NEWS· 4 days agoThe firm owned 33,335 shares of the pharmaceutical company’s stock after selling 562 shares during the quarter. NBC Securities Inc.’s holdings in GSK were ...
Leo Wealth LLC Purchases New Shares in GSK plc (NYSE:GSK)
ETF DAILY NEWS· 6 days agoLeo Wealth LLC purchased a new stake in GSK plc (NYSE:GSK – Free Report) during the 4th quarter, according to the company in its most recent filing with ...
AI Regulation Must Not Stifle Growth, GSK CEO Says
Barrons.com· 3 days agoGSK is betting on AI to boost innovation for its pipeline as investor concerns cloud over the company's research-and-development productivity, but a...
Major drug companies cap asthma medication costs at $35 per month
WISN 12 Milwaukee· 2 days agoMajor pharmaceutical companies have agreed to cap out-of-pocket costs for some asthma patients at...
Baird lifts Mirum Pharmaceuticals shares target on study results By Investing.com
Investing.com· 7 days agoOn Monday, Baird increased its price target on Mirum Pharmaceuticals (NASDAQ:MIRM) shares to $39...
Health Care Roundup: Market Talk
The Wall Street Journal· 3 days agopharmaceutical company’s refocused R&D strategy, with investments concentrated in the U.K., U.S., and Europe...
As big pharma exits Nigeria, asthma patients face spiralling costs
Al Jazeera· 5 days agoThe following week, when she went out in Ibadan city to replace her old Ventolin inhaler, the asthma...